Agilent Launches FDA-Cleared Digital Pathology Scanner in U.S.
Event summary
- Agilent launched the S540MD Slide Scanner System in the U.S. after FDA clearance.
- The scanner is a rebranded version of Hamamatsu’s NanoZoomer S540MD.
- System features include 540-slide capacity, continuous loading, and AI workflow integration.
- Follows January 2026 European launch in 14 markets.
The big picture
Agilent’s U.S. launch of the S540MD Slide Scanner System underscores the growing demand for digital pathology solutions in clinical labs. The scanner’s high-throughput capabilities and AI compatibility align with broader industry trends toward automation and data-driven diagnostics. With $6.95 billion in 2025 revenue, Agilent is positioning itself as a key player in the digital transformation of pathology workflows.
What we're watching
- Market Adoption
- How quickly U.S. labs will integrate the S540MD into existing workflows.
- Competitive Positioning
- Whether Agilent can differentiate itself in the crowded digital pathology space.
- AI Integration
- The pace at which AI-powered diagnostics will drive demand for high-throughput scanners.
Related topics